BridgeBio Pharma, Inc. (BBIO)
70.91
-0.12
(-0.17%)
USD |
NASDAQ |
Mar 17, 16:00
70.91
0.00 (0.00%)
After-Hours: 18:39
BridgeBio Pharma Total Liabilities (Quarterly) : 3.013B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.526B |
| Pfizer Inc. | 121.38B |
| Mirum Pharmaceuticals, Inc. | 528.12M |
| Supernus Pharmaceuticals, Inc. | 552.44M |
| Cogent Biosciences, Inc. | 301.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 936.02M |
| Shareholders Equity (Quarterly) | -2.087B |
| Debt to Equity Ratio | -1.308 |
| Current Ratio | 2.770 |
| Net Debt Paydown Yield | -1.34% |